Avid Bioservices Shares Outstanding 2006-2021 | CDMO

Avid Bioservices shares outstanding from 2006 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Avid Bioservices Annual Shares Outstanding
(Millions of Shares)
2021 59
2020 56
2019 56
2018 47
2017 37
2016 31
2015 26
2014 23
2013 17
2012 12
2011 9
2010 7
2009 6
2008 6
2007 5
2006 5
2005 4
Avid Bioservices Quarterly Shares Outstanding
(Millions of Shares)
2021-07-31 64
2021-04-30 59
2021-01-31 60
2020-10-31 57
2020-07-31 57
2020-04-30 56
2020-01-31 56
2019-10-31 56
2019-07-31 56
2019-04-30 56
2019-01-31 56
2018-10-31 56
2018-07-31 56
2018-04-30 47
2018-01-31 45
2017-10-31 45
2017-07-31 45
2017-04-30 37
2017-01-31 37
2016-10-31 35
2016-07-31 34
2016-04-30 31
2016-01-31 32
2015-10-31 29
2015-07-31 28
2015-04-30 26
2015-01-31 26
2014-10-31 26
2014-07-31 26
2014-04-30 23
2014-01-31 23
2013-10-31 22
2013-07-31 21
2013-04-30 17
2013-01-31 19
2012-10-31 16
2012-07-31 15
2012-04-30 12
2012-01-31 12
2011-10-31 11
2011-07-31 10
2011-04-30 9
2011-01-31 9
2010-10-31 8
2010-07-31 8
2010-04-30 7
2010-01-31 7
2009-10-31 7
2009-07-31 7
2009-04-30 6
2009-01-31 6
2008-10-31 6
2008-07-31 6
2008-04-30 6
2008-01-31 6
2007-10-31 6
2007-07-31 6
2007-04-30 5
2007-01-31 6
2006-10-31 6
2006-07-31 5
2006-04-30 5
2006-01-31 5
2005-10-31 5
2005-07-31 5
2005-04-30 4
2005-01-31 4
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.351B $0.096B
Avid Bioservices, Inc. is a dedicated contract development and manufacturing organization focused on development and cGMP manufacturing of biopharmaceutical products derived from mammalian cell culture. The company provides process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. It also offer process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization. Avid Bioservices Inc., formerly known as Peregrine Pharmaceuticals Inc., is based in TUSTIN, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71